Login

The CEO of Freenet AG discusses the company's strategic ambitions in an interview 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Cesar Gon, CEO of CI&T, says 'We are living through a technological revolution' in O Globo.
00:10:00
A Masterclass with Latham & Watkins and the US Chamber of Commerce | Sarah E. Fortt - Partner of Latham & Watkins
00:10:00
"Uncovering Investment Opportunities through Value Investing in Japanese Equities: Insights from Andrew McCagg, Portfolio Manager at Nomura Asset Management"
00:10:00
Professor Robert Kaufman on the Legacy of the Bush Doctrine and the Iraq War|Robert Kaufman,Professor,Pepperdine State University
00:10:00
The Importance of Stress Testing Your Financial Plan: Navigating Uncertainty |Eric Lawton, President , Impact Financial.
00:10:00
Group Philippines includes Alfredo Pascual, CEO of the Institute of Corporate Directors and Independent Director of SM Investments Corp., and Jet Pampolina.|Kevin Andrew L.Tan currently works at Alliance Global Group, Inc., as Vice Chairman & Chief Execut
00:10:00
Capital- Building Engaged Crypto Communities|Niv Dror,Managing Partner,Shrug Capital
00:10:00
The firm has $1.5B in total capital committed and has built a community|Armaan Ali,Co-Founder, CEO, and Managing Partner,Human Capital
00:10:00
FESA4 Investment Analysis: Historical Overview & Financial Evaluation | Silvano Andrade - CEO of Companhia de Ferro Ligas da Bahia - FERBASA
00:10:00
Asetek Liquid Cooling Moves Delivers Savings and Flexibility for HPC | André Eriksen, CEO, Asetek A/SASTK:OSL
00:10:00
Brian Cox, SurgePays CEO, discusses current $SURG fundamentals and more in this interview.|Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;
00:10:00
Understanding the Dynamics of Financial Regulation in Emerging Markets |Brandon White, Managing Director, Charlesbank Capital Partners.

© 2017 - Neuhu+